0000000000181720

AUTHOR

Salvatore Gruttadauria

showing 39 related works from this author

Guillain-Barré syndrome after orthotopic liver transplantation: A clinical manifestation of immune reconstitution inflammatory syndrome?

2018

Guillain-Barrè Syndrome, as part of the spectrum of dysimmune neuropathies, is unexpected to occur in immunocompromised hosts. We describe a clinical case of Guillain-Barrè syndrome, occurred a few weeks after a liver transplant, and we postulate that our case would satisfy all requirements to explain this peripheral nervous system complication as a clinical manifestation of an Immune reconstitution inflammatory syndrome. In this setting of liver transplantation, complicated by potentially multiple infective triggers, reduction of immunosuppression and reversal of pathogen-induced immunosuppression, through antimicrobial therapy, may have led to pro-inflammatory response. The pro-inflammato…

medicine.medical_treatmentLiver transplantationGuillain-Barre SyndromeTacrolimus030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineImmune systemImmune reconstitution inflammatory syndromemedicineHumansImmune reconstitution inflammatory syndromeAcute demyelinating polyneuropathyImmunosuppression TherapyInflammationLiver transplantationGuillain-Barre syndromebusiness.industryImmunosuppressionGeneral Medicinemedicine.diseaseGuillain-Barré syndromeTacrolimusPathophysiologyTacrolimuImmunologyAcute demyelinating polyneuropathy; Guillain-Barré syndrome; Immune reconstitution inflammatory syndrome; Liver transplantation; TacrolimusSurgeryFemaleNeurology (clinical)Complicationbusiness030217 neurology & neurosurgery
researchProduct

Clinical and Molecular-Based Approach in the Evaluation of Hepatocellular Carcinoma Recurrence after Radical Liver Resection

2021

Background: Hepatic resection remains the treatment of choice for patients with early-stage HCC with preserved liver function. Unfortunately, however, the majority of patients develop tumor recurrence. While several clinical factors were found to be associated with tumor recurrence, HCC pathogenesis is a complex process of accumulation of somatic genomic alterations, which leads to a huge molecular heterogeneity that has not been completely understood. The aim of this study is to complement potentially predictive clinical and pathological factors with next-generation sequencing genomic profiling and loss of heterozygosity analysis. Methods: 124 HCC patients, who underwent a primary hepatic …

Cancer Researchmedicine.medical_specialtyHepatitis C virusSubgroup analysisLower riskmedicine.disease_causelcsh:RC254-282GastroenterologyArticlePathogenesisLoss of heterozygositynext-generation sequencing.03 medical and health sciences0302 clinical medicineInternal medicineMedicinePTENHCCHCC recurrencebiologybusiness.industrylcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensmedicine.diseaseOncology030220 oncology & carcinogenesisHepatocellular carcinomaliver resectionbiology.proteinnext-generation sequencingloss of heterozygosity030211 gastroenterology & hepatologyLiver functionbusinessCancers
researchProduct

Significance of the effective remnant liver volume in major hepatectomies

2005

The aim of this study is to identify the minimum safe amount of effective remnant liver volume (ERLV) in patients undergoing a major hepatectomy. Thirty-eight consecutive major hepatectomies (resection of ≥3 Couinaud segments) performed between July 1999 and March 2004 in which a frozen section liver biopsy was obtained were included. No patient had chronic viral hepatitis, cirrhosis, or cholestasis. The total liver volume (TLV) was calculated using the Vauthey formula, and the postsurgical liver volume (PSLV) was derived by subtracting the estimated volume of liver resected from the TLV. The PSLV minus the percentage of macrovesicular steatosis as nonfunctional liver was defined as the ef…

Malemedicine.medical_specialtyCirrhosisRisk AssessmentCohort StudiesPostoperative ComplicationsCholestasisLiver Function TestsmedicineHepatectomyHumansSurvival analysisProbabilityRetrospective StudiesCohort Studies; Female; Follow-Up Studies; Hepatectomy; Humans; Liver; Liver Function Tests; Liver Neoplasms; Male; Organ Size; Postoperative Complications; Probability; Retrospective Studies; Risk Assessment; Survival AnalysisFrozen section proceduremedicine.diagnostic_testbusiness.industryLiver NeoplasmsRetrospective cohort studyGeneral MedicineOrgan Sizemedicine.diseaseSurvival AnalysisSurgerySettore MED/18 - Chirurgia GeneraleLiverLiver biopsyFemaleLiver function testsbusinessViral hepatitisFollow-Up Studies
researchProduct

Liver Transplantation for Unresectable Intrahepatic Cholangiocarcinoma: The Role of Sequencing Genetic Profiling

2021

Simple Summary Intrahepatic cholangiocarcinoma is a rare disease with increasing incidence and mortality still characterized by an insufficient clinical outcome. Growing attention has recently surrounded this disease, and liver transplantation has emerged as a novel curative treatment for cholangiocarcinoma, along with a better understanding of genetic alterations potentially capable of driving tumorigenesis. The aim of this paper is to present a clinical description of our case series of patients affected by intrahepatic cholangiocarcinoma and by mixed forms of hepatocellular and cholangiocellular carcinoma, together with a genomic profiling of mutations occurring in a panel of genes relev…

Cancer ResearchLiver tumorliver transplantationbusiness.industrymedicine.medical_treatmentWnt signaling pathwayCancerNeoplasms. Tumors. Oncology. Including cancer and carcinogensLiver transplantationmedicine.diseasemedicine.disease_causeArticlenext-generation sequencing.Oncologyintrahepatic cholangiocarcinomamedicineCancer researchnext-generation sequencingKRASCarcinogenesisbusinessPI3K/AKT/mTOR pathwayIntrahepatic CholangiocarcinomaRC254-282intrahepatic cholangiocarcinoma; liver transplantation; next-generation sequencingCancers
researchProduct

Impact of Italian Score for Organ Allocation System on Deceased Donor Liver Transplantation: A Monocentric Competing Risk Time-to-Event Analysis

2019

Background: Liver transplantation (LT) is the only definitive and curative treatment for patients with end-stage liver disease and hepatocellular carcinoma. We aimed to evaluate the impact of the Italian score for organ allocation (ISO) in terms of the waiting-list mortality, probability of LT, and patient survival after LT. Patient and methods: All of the adult patients on the waiting list for LT at our institute from January 2014 to December 2017 were included in the study. The probabilities of death while on the waiting list, dropout from the list, and LT were compared by means of cumulative incidence functions, in a competing risk time-to-event analysis setting. Uni- and multivariable l…

AdultMalemedicine.medical_specialtyCarcinoma HepatocellularTime FactorsWaiting Listsmedicine.medical_treatmentLiver transplantationCompeting risksLogistic regressionSeverity of Illness IndexGroup BEnd Stage Liver DiseaseLiver diseaseRisk FactorsInternal medicinemedicineHumansCumulative incidenceSurvival analysisRetrospective StudiesTransplantationbusiness.industryLiver NeoplasmsMiddle Agedmedicine.diseaseLiver TransplantationItalyHepatocellular carcinomaSurgeryFemalebusiness
researchProduct

Complications in Immunosuppressive Therapy of Liver Transplant Recipients

2011

BACKGROUND: In liver transplantation (LT), modern immunosuppressive protocol is focused on early corticosteroid (CS) weaning. The aim of the study was to investigate all early transplant-related complications using Clavien grading system, in order to identify a significant relation in two homogenous groups of consecutive liver transplanted patients, only different for steroid avoidance in immunosuppressive regimen. MATERIALS AND METHODS: One group was treated with a tacrolimus-based CS-free immunosuppressive protocol, the other one underwent tacrolimus plus low dose CS therapy. The preoperative continuous variables analyzed were age, gender, model for end-stage liver disease (MELD) score, a…

AdultGraft RejectionMalemedicine.medical_specialtyAdolescentmedicine.drug_classmedicine.medical_treatmentSettore MED/50 - Scienze Tecniche Mediche ApplicatecomplicationLiver transplantationGastroenterologyTacrolimusYoung AdultLiver diseasePostoperative ComplicationsAdrenal Cortex HormonesInternal medicinemedicineHumansAgedRetrospective Studiesimmunosuppressionbusiness.industryIncidenceLiver DiseasesIncidence (epidemiology)ImmunosuppressionMiddle Agedmedicine.diseaseTacrolimusLiver TransplantationSurgerySurvival RateRegimenCorticosteroidDrug Therapy CombinationFemaleSurgeryrejectionComplicationbusinessImmunosuppressive AgentsJournal of Surgical Research
researchProduct

Laparoscopic Microwave Thermal Ablation for the Treatment of Hepatocellular Carcinoma in Chronic Hepatic Patients

2020

Background: Laparoscopic microwave thermal ablation (LMWTA) is a well-established alternative treatment to liver resection for treatment of liver tumors. The aim of this study was to describe our experience in LMWTA for hepatocellular carcinoma (HCC) in chronic hepatic patients. Materials and Methods: A study group of 61 consecutive HCC patients treated with LMWTA from January, 2013 to May, 2020 were considered for this study. Patient characteristics, liver function test, operational characteristics, and complications were recorded. Results: Of the 61 patients who underwent LMWTA, median age was 64 (interquartile range [IQR]: 58-71) years, mean body mass index was 26.2 (IQR: 23.2-29.4); 44 …

Liver CirrhosisMaleLaparoscopic surgerymedicine.medical_specialtyCarcinoma Hepatocellularmedicine.medical_treatmentHepatitis C virusmedicine.disease_causeGastroenterologyLiver diseasePregnancymicrowave thermoablationInterquartile rangeInternal medicinemedicineHepatectomyHumansRisk factorMicrowavesAgedmedicine.diagnostic_testbusiness.industryLiver NeoplasmsHyperthermia Inducedhepatocellular carcinomaHepatitis C ChronicMiddle Agedmedicine.diseaselaparoscopic surgerySurgeryHepatocellular carcinomaCatheter AblationFemaleLaparoscopySurgeryLiver function testsbusinessBody mass indexJournal of Laparoendoscopic & Advanced Surgical Techniques
researchProduct

Selective decontamination of the digestive tract in adult-to-adult living related liver transplant patients: a single centre experience

2008

AdultMaleMicrobiology (medical)medicine.medical_specialtyAdolescentSelective decontaminationSettore BIO/19 - Microbiologia GeneraleChemopreventionPostoperative ComplicationsmedicineHumansPharmacology (medical)Intensive care medicineDecontaminationAgedANTIBIOTIC THERAPY SELECTIVE DECONTAMINATION GRAM POSITIVE AND GRAM NEGATIVE BACTERIA TRANSPLANTbusiness.industryBacterial InfectionsGeneral MedicineMiddle AgedAnti-Bacterial AgentsLiver TransplantationGastrointestinal TractSingle centreInfectious DiseasesFemaleTransplant patientDigestive tractbusinessInternational Journal of Antimicrobial Agents
researchProduct

Adult to Adult Living Donor Liver Transplantation in Recipients with Low MELD: A Strategy Intended to Overcome Donor Shortage

2020

Recent series have demonstrated advantages of living donor over deceased donor liver transplantation, with particular benefit for those with low model for end-stage liver disease score. The logic underlying the transplantation of patients before they become too sick is intuitive. It reduces mortality and drop outs from the waiting list and makes transplant surgery less demanding. Those principles have to be balanced with donor safety and transplant benefit for the recipient avoiding early, futile transplantation. The authors report a case of adult to adult right lobe living donor liver transplantation performed for a recipient affected by primary biliary cirrhosis with MELD score of 15, in …

MalePhysiologymedicine.medical_treatmentLiver transplantationSeverity of Illness IndexLiver diseasePostoperative Complications0302 clinical medicinePrimary biliary cirrhosisTransplant surgeryLiving DonorsLiver Transplantation.Liver resectionLiver Cirrhosis BiliaryGastroenterologyCone-Beam Computed TomographyMiddle AgedTreatment Outcomesurgical procedures operativeItalyLiver030220 oncology & carcinogenesisFemaleRisk Adjustment030211 gastroenterology & hepatologyLiving donor liver transplantationHumanAdultmedicine.medical_specialtyTissue and Organ ProcurementClinical Decision-MakingTime-to-TreatmentEnd Stage Liver Disease03 medical and health sciencesInternal medicineSeverity of illnessmedicineHepatectomyHumansIntensive care medicineLiver transplantationbusiness.industryLiving donor liver transplantationHepatologymedicine.diseasePleural EffusionTransplantationSurgeryPostoperative Complicationbusiness
researchProduct

Neurological Screening in Elderly Liver Transplantation Candidates: A Single Center Experience.

2022

Background: Cerebral small vessels disease (cSVD) is an age-related disorder and risk factor for stroke and cognitive/motor impairments. Neurological complications (NCs) are among the causes of adverse outcomes in older liver transplant recipients. This study sought to determine whether cSVD predicts acute NCs in over 65-year-old liver transplant patients. Methods: Data were collected, from a retrospective medical chart review, of 22 deceased donor liver transplant recipients aged 65 years or older with a pre-operative brain magnetic resonance imaging (MRI). We used the Fazekas score (0–3) as a quantitative measurement of the vascular lesion load seen in the MRI. We analyzed all post-operat…

cerebral small vessel disease; liver transplantation; brain magnetic resonance imaging elderly age-related diseasesLiver transplantationCerebral small vessel diseaseNeurology (clinical)Brain magnetic resonance imaging elderly age-related diseasesNeurology international
researchProduct

Acute and reversible Pisa syndrome as unusual presentation of portosystemic encephalopathy

2020

Abstract We present the first case of acute and reversible Pisa Syndrome, as a clinical manifestation of a portosystemic encephalopathy bout occurring in a patient affected with cirrhosis and clinical-radiological signs of acquired hepatocerebral degeneration, without exposure to psychotropic medications. A 62 year-old man suffering from cirrhosis was admitted to our hospital for sudden onset of mild confusion and postural change. He was observed walking and standing with a tilt toward the right during the last two hours. On neurological examination, he showed bilateral asterixis and extrapyramidal signs. Clinical diagnosis of Pisa Syndrome was made in a setting of raised serum ammonia. A b…

Liver CirrhosisMalemedicine.medical_specialtyCerebellumCirrhosisNeurological examination03 medical and health sciences0302 clinical medicineNeuroimagingAcquired hepatocerebral degenerationInternal medicineBasal gangliaHumansMedicinePortosystemic encephalopathyAsterixisPisa syndrome Axial dystonia Portosystemic encephalopathy Acquired hepatocerebral degeneration Orthotopic liver transplantmedicine.diagnostic_testbusiness.industryParkinsonismOrthotopic liver transplantGeneral MedicineMiddle Agedmedicine.diseaseAxial dystoniaDystoniaPisa syndromeGlobus pallidusmedicine.anatomical_structureHepatic Encephalopathy030220 oncology & carcinogenesisCardiologySurgeryNeurology (clinical)medicine.symptombusiness030217 neurology & neurosurgery
researchProduct

Left Spigelian Hernia in Super-Obese Patient: A Case-Report.

2011

Abstract: We report a case in which a giant Spigelian hernia presented with severe, persistent abdominal pain in a 62- year-old super-obese woman with a history of total abdominal hysterectomy-bilateral salpingo-oopherectomy at the age of 40 years for benign neoplasia, who later underwent open hernia repair (maximal diameter of the hernia sac: 21 cm) because of the development of compartment syndrome. Afterward, although a large incarcerated hernia disease was found, the sac removal was technically difficult and an open procedure was carried out, with double-mesh placement. No complications were recorded during the post-operative course. We report a difficult issue related to the diagnosis …

medicine.medical_specialtySettore MED/18 - Chirurgia GeneraleSpigelian herniaSuper obesebusiness.industrySpigelian hernia super-obesity abdominal wall hernia repair.medicinemedicine.diseasebusinessSurgery
researchProduct

Imaging of hepatocellular carcinoma recurrence after liver transplantation

2023

Abstract Liver transplantation (LT) provides the highest survival benefit to patients with unresectable hepatocellular carcinoma (HCC). The Milan criteria have been developed for the selection of LT candidates with the goal of improving survival and maintaining an acceptable risk of HCC recurrence. Despite this, recurrence of HCC after LT occurs in up to 20% of cases and represents a major concern due to the poor prognosis of these patients. Furthermore, several extended criteria for the selection of LT candidates have been proposed to account for the growing demand for organs and the resultant increase in the risk of HCC recurrence. Radiologists should be aware that HCC can recur after LT…

Liver transplantationHepatocellular carcinomaRecurrenceRadiology Nuclear Medicine and imagingInsights into Imaging
researchProduct

Case report: Trans-papillary free stenting of the cystic duct and of the common bile duct in a double biliary ducts anastomoses of a right lobe livin…

2021

Abstract Background One of the major issues related to the living donor liver transplantation recipient outcome is still the high rate of biliary complication, especially when multiple biliary ducts are present and multiple anastomoses have to be performed. Case presentation and conclusion We report a case of adult-to-adult right lobe living donor liver transplantation performed for a recipient affected by alcohol-related cirrhosis with MELD score of 17. End-stage liver disease was complicated by refractory ascites, portal hypertension, small esophageal varices and portal gastropathy, hypersplenism, and abundant right pleural effusion. Here in the attached video we described the adult-to-ad…

Malemedicine.medical_specialtyCirrhosismedicine.medical_treatmentBiliary anastomoseslcsh:SurgeryAnastomosisLiver transplantationEsophageal varicesCholestasisLiver Cirrhosis AlcoholicmedicineLiving DonorsHumansCommon Bile DuctCommon bile ductbusiness.industryLiving donor liver transplantationAnastomosis SurgicalCystic Ductlcsh:RD1-811General MedicineMiddle Agedmedicine.diseaseSurgeryLiver TransplantationTransplantationmedicine.anatomical_structureTreatment OutcomeCystic ductSurgeryStentsBile DuctsbusinessResearch ArticleBMC surgery
researchProduct

Thyroid ectopia of the liver: An unusual diagnosis with contrast-enhanced EUS (with video)

2019

No abstract available

medicine.medical_specialtyHepatologybusiness.industrymedia_common.quotation_subjectThyroidGastroenterologyMEDLINE.Text miningmedicine.anatomical_structuremedicineContrast (vision)Radiology Nuclear Medicine and imagingRadiologybusinessmedia_commonImages and Videos
researchProduct

Impact of margin status on long-term results of liver resection for hepatocellular carcinoma: single-center time-to-recurrence analysis

2020

Occult metastasis from the initial tumor and a de novo second primary hepatocellular carcinoma (HCC) were recognized as the main causes for the onset of early and late HCC recurrence, after liver resection (LR). This study aims to compare the time to recurrence after LR for HCC in which a margin ≤ 1 mm or > 1 mm was achieved. A single-center retrospective study involving 256 patients was conducted from June 2005 to June 2019. HCC patients resected with a radical surgical approach were investigated and stratified into groups A (resection margins ≤ 1 mm) and B (> 1 mm), as measured on final pathologic assessment. Kaplan–Meier estimators were used to estimate the probability of recurrenc…

medicine.medical_specialtyCarcinoma HepatocellularTime FactorsHepatocellular carcinomaHepatocellular carcinoma; Liver resection; Liver transplantation; Margin status; Outcome030230 surgerySingle CenterGastroenterologyGroup BMetastasis03 medical and health sciences0302 clinical medicineInternal medicineHepatocellular carcinoma Liver resection Liver transplantation Margin status Outcome Carcinoma Hepatocellular Liver Neoplasms Neoplasm Recurrence Local Neoplasms Second Primary Time Factors Hepatectomy Margins of ExcisionEpidemiologyHepatectomyHumansMedicineMargin statusPathologicalOutcomeLiver transplantationLiver resectionbusiness.industryProportional hazards modelLiver NeoplasmsMargins of ExcisionNeoplasms Second PrimaryRetrospective cohort studymedicine.diseaseSurgery030220 oncology & carcinogenesisHepatocellular carcinomaSurgeryNeoplasm Recurrence Localbusiness
researchProduct

Impact of Extended-Criteria Donor Liver Grafts on Benchmark Metrics of Clinical Outcome After Liver Transplantation: A Single Center Experience.

2020

Abstract Background The adoption of extended criteria for donors remains the best strategy to widen the pool of available liver graft against the chronic shortage of donors. Benchmarking in liver transplantation (LT) offers the unprecedented opportunity to compare clinical outcome measures to a set of validated reference values. We aimed to evaluate the impact of marginal grafts usage in a cohort of low-risk benchmark cases from an area with a very low rate of deceased donation. Methods A cohort of low-risk benchmark cases was identified from all adult patients who underwent LT at our center. Among these patients, those transplanted with a graft from an extended-criteria donor (ECD) were id…

AdultMalemedicine.medical_specialtymedicine.medical_treatment030230 surgeryLiver transplantationSingle Centerlaw.inventionDonor Selection03 medical and health sciences0302 clinical medicinePostoperative ComplicationslawRisk FactorsmedicineLiving DonorsHumansRetrospective StudiesTransplantationDonor selectionbusiness.industryIncidenceGraft SurvivalPostoperative complicationRetrospective cohort studyMiddle Agedmedicine.diseasePrognosisIntensive care unitSurgeryLiver TransplantationBenchmarkingHepatocellular carcinomaCohort030211 gastroenterology & hepatologySurgeryFemalebusinessTransplantation proceedings
researchProduct

Importance of sarcopenia parameter changes after living donor liver transplantation

2017

The systemic role of muscle tissue is strengthened by the large system of hormones, chemokines and other mediators that constitute a dense network of communication between the skeletal muscle and the liver (1,2). This, associated with the evidence of a progressive malnutrition and depletion of muscle mass in end-stage liver disease (ESLD) patients, has led many to study the role of sarcopenia and its systemic effects in this setting, and to identify it as critical risk factor for post- liver transplantation (LT) mortality (3-5). Englesbe and colleagues found a direct correlation between central sarcopenia, measured by computerized tomography (CT), the total area of the psoas muscle (psoas a…

Muscle tissueChemokinePathologymedicine.medical_specialtybiologybusiness.industrySkeletal muscle030230 surgerymedicine.disease03 medical and health sciences0302 clinical medicinemedicine.anatomical_structureSarcopenia Liver TransplantationSarcopeniamedicinebiology.protein030211 gastroenterology & hepatologyLiving donor liver transplantationbusinessLetter to the EditorHormone
researchProduct

Are radiological endpoints surrogate outcomes of overall survival in hepatocellular carcinoma treated with transarterial chemoembolization?

2021

Background& Aims: Time to progression (TTP) and progression-free survival (PFS) are commonly used as surrogate endpoints in oncology trials. We aimed to assess the surrogacy relationship of TTP and PFS with overall survival (OS) in studies of transarterial chemoembolization (TACE) for unresectable hepatocellular carcinoma (u-HCC) by innovative methods. Methods: A search of databases for studies of TACE for u-HCC reporting both OS and TTP or PFS was performed. Individual patient data were extracted from TTP/PFS and OS Kaplan-Meier curves of TACE arms. Pooled median TTP and OS were obtained from random-effect model. The surrogate relationships of hazard ratios (HRs) and median TTP for OS …

Oncologymedicine.medical_specialtyCarcinoma Hepatocellularoverall survivaltransarterial chemoembolizationtime to progressionSystemic therapy03 medical and health sciences0302 clinical medicineInternal medicinemedicineOverall survivalsurrogate endpointHumansProgression-free survivalChemoembolization TherapeuticneoplasmsNeoplasm StagingHepatologybusiness.industrySurrogate endpointLiver NeoplasmsHazard ratiohepatocellular carcinomamedicine.diseaseCombined Modality TherapyConfidence intervalTreatment Outcomesurrogate endpoints030220 oncology & carcinogenesisHepatocellular carcinomaRadiological weaponDisease Progression030211 gastroenterology & hepatologyRadiologybusinessprogression-free survival
researchProduct

Risk factors for bile leakage after liver resection for neoplastic disease.

2022

Biliary leakage (BL) remains the most frequent and feared complication after hepatoresective surgery. Placement of the abdominal drainage at the end of liver surgery remains controversial due to the delicate balance between risks and potential benefits in case of BL. The study was aimed to detect possible risk factors for BL occurrence after liver surgery. We enrolled all oncologic patients who underwent liver resection from June 2016 to March 2021. BL was diagnosed according to the ISGLS definition. We have examined demographic characteristics of the patients, type of neoplasia, presence of cirrhosis, neoadjuvant chemotherapy and type of intervention. Uni- and multivariable analyses were p…

Liver resectionBiliary Tract DiseasesLiver NeoplasmsAnastomotic LeakPost-hepatectomy complicationsPostoperative ComplicationsBile leakageRisk FactorsBileDrainageHepatectomyHumansSurgeryPostoperative drainageRetrospective StudiesUpdates in surgery
researchProduct

Enhanced Recovery after Implementation of Surgery Protocol in Living Kidney Donors: The ISMETT Experience

2019

Abstract Introduction Laparoscopic living donor nephrectomy (LLDN) has become the standard procedure for living kidney transplantation. Enhanced recovery after surgery (ERAS) is a multimodal perioperative management aimed at facilitating rapid patient recovery after major surgery by modifying the response to stress induced by exposure to surgery. This association can further reduce hospital stay, surgical stress, and perioperative morbidity of living kidney donors. Material and methods In this retrospective analysis conducted at our institute, we compared the first 21 patients who underwent LLDN enrolled with the ERAS protocol with 55 patients who underwent LLDN with the fast-track protocol…

AdultMalemedicine.medical_specialtySurgical stressNephrectomyPatient ReadmissionPostoperative ComplicationsEnhanced recoveryISMETTLiving DonorsMedicineHumansKidney transplantationAgedRetrospective StudiesProtocol (science)TransplantationKidneybusiness.industryRetrospective cohort studyPerioperativeRecovery of FunctionLength of StayMiddle Agedmedicine.diseaseKidney TransplantationSurgerymedicine.anatomical_structureTissue and Organ HarvestingSurgeryFemaleLaparoscopybusiness
researchProduct

Comparison of two different techniques of reperfusion in adult orthotopic liver transplantation

2006

: The aim of this study was to determine the impact of two reperfusion techniques on the peri-operative hemodynamic changes and early post-operative graft function of adult patients undergoing orthotopic liver transplantation. Material and methods: From June 2003 to May 2004, 50 consecutive liver transplants were performed and divided into two groups: group A, 25 patients, portal vein flush with 500 cm3 of Ringer's lactate without vena caval venting. Group B, 25 patients, vena caval venting with no portal vein flush. Donor and recipient characteristics were similar in both groups. Sixty-four different parameters were analyzed, and Pearson's χ2 test and t-test were used for statistical analy…

InferiorAdultMalemedicine.medical_specialtyOrthotopic liver transplantation; Post-reperfusion syndrome; Reperfusion technique; Adolescent; Adult; Aged; Aged 80 and over; Child; Female; Humans; Liver Transplantation; Male; Middle Aged; Portal Vein; Reperfusion; Tissue Donors; Vena Cava Inferior; TransplantationVena CavaAdolescentOrthotopic liver transplantationmedicine.medical_treatmentPortal veinHemodynamicsPost-reperfusion syndromeVena Cava InferiorLiver transplantationVena caval80 and overmedicineHumansStatistical analysisChildAgedAged 80 and overReperfusion techniqueTransplantationAdult patientsPortal Veinbusiness.industrySignificant differenceMiddle AgedSettore ING-IND/35 - Ingegneria Economico-GestionaleTissue DonorsLiver TransplantationSurgerySettore MED/18 - Chirurgia GeneraleReperfusioncardiovascular systemFemaleOrthotopic liver transplantationbusinessClinical Transplantation
researchProduct

Liver Perfusate Natural Killer Cells from Deceased Brain Donors and Association with Acute Cellular Rejection after Liver Transplantation: A Time-to-…

2019

Background The ability to predict which recipients will successfully complete their posttransplant clinical course, which is crucial for liver transplant (LT) programs. The assessment of natural killer (NK) cell subset determined by flow cytometry from a monocentric series of consecutive liver perfusates could help identify risk factors portending adverse LT outcomes. Methods Liver perfusates were collected during the back-table surgical time after the procurement procedures for donors after brain death. Lymphocytic concentrations and phenotypes were matched with donors after brain death characteristics and indications, timing, surgical techniques, outcomes, and biopsy-proven acute cellular…

AdultGraft RejectionMaleTime FactorsAcute cellular rejectionmedicine.medical_treatment030230 surgeryLiver transplantationFlow cytometry03 medical and health sciences0302 clinical medicineMedicineHumansKiller CellsLiver immunologyAgedTransplantationmedicine.diagnostic_testbusiness.industryClinical courseMiddle AgedTissue DonorsLiver TransplantationKiller Cells NaturalLiverT cell subsetImmunologyAcute DiseaseNaturalAcute Disease Adult Aged Female Graft Rejection Humans Killer Cells Natural Liver Liver Transplantation Male Middle Aged Time Factors Tissue Donors030211 gastroenterology & hepatologyFemalebusiness
researchProduct

Early Regeneration of the Remnant Liver Volume after Right Hepatectomy for Living Donation: A Multiple Regression Analysis.

2012

Early liver regeneration was studied in a series of 70 patients who underwent right hepatectomy for living donation between November 2004 and January 2010. Liver regeneration was evaluated with multidetector computed tomography (MDCT) at a mean of 61.07 days after surgery. Presurgical variables [eg, age, weight, height, body mass index (BMI), liver function tests, creatinine levels, platelet counts, international normalized ratio, and glucose levels] and variables detected with preoperative MDCT imaging [eg, main portal vein diameter, steatosis, original liver volume, and spleen volume (SV)] were investigated as potential predictors of liver regeneration. The future remnant liver volume (FR…

AdultMalemedicine.medical_specialtyEarly liver regeneration remnant liver volume right hepatectomy living donationDatabases Factualmedicine.medical_treatmentEarly RegenerationUrologyLiver transplantationBody Mass Indexchemistry.chemical_compoundLiver Function TestsMultidetector Computed TomographyLiving DonorsmedicineHepatectomyHumansRetrospective StudiesTransplantationCreatinineHepatologymedicine.diagnostic_testbusiness.industryLiver DiseasesMiddle Agedmedicine.diseaseLiver regenerationLiver RegenerationLiver TransplantationSurgeryTreatment OutcomeLiverchemistryRegression AnalysisFemaleSurgerySteatosisHepatectomybusinessLiver function testsBody mass index
researchProduct

Use of Hepatitis C-Positive Deceased Liver Donors in Response to the Organ Shortage in an Endemic Area

2017

The region of Sicily, Italy, is witnessing a chronic organ shortage. Thus, to face this critical issue, the use of marginal donors has increased over time. An example of marginal donor expansion is the use of liver donors who are positive for the hepatitis C antibody (HCV+) for HCV+ patients requiring liver transplantation (LT). In view of new advances in HCV therapy, including direct-acting agents (DAAs) to treat HCV in the post-transplant setting, our study focused on a monocentric experience in a series of consecutive LTs performed in adult patients receiving HCV+ liver donor allografts. From 2003 to 2016 at our institute we performed 10 LT using HCV+ deceased donors. In particular, the …

AdultMalemedicine.medical_specialtymedicine.medical_treatmentHepacivirusHepacivirusLiver transplantationAntiviral AgentsGastroenterologyDonor SelectionFibrosisInternal medicinemedicineHumansAntiviral Agents; Donor Selection; Hepacivirus; Liver TransplantationSurvival rateAgedRetrospective StudiesTransplantationbiologybusiness.industryDonor selectionGraft SurvivalGeneral MedicineHepatitis CMiddle Agedmedicine.diseasebiology.organism_classificationHepatitis CTissue DonorsIshak ScoreLiver TransplantationSurvival RateItalyLiverFemaleSteatosisbusinessAntiviral agents Donor selection Hepacivirus Liver transplantation Adult Graft Survival Hepatitis C Liver Liver Transplantation Middle Aged Retrospective Studies Survival Rate Tissue DonorsAnnals of Transplantation
researchProduct

Crucial Role of Extended Criteria Donors in Deceased Donor Single Kidney Transplantation to Face Chronic Shortage in the Heart of the Mediterranean B…

2019

Background: The gap between organ availability and patients on the waiting list for deceased donor kidney transplants has resulted in the wide use of extended criteria donors (ECDs).We aimed to compare the surgical outcomes of single kidney transplantation (KT) performed at our institute with standard criteria donor (SCD) or ECD grafts, according to the Organ Procurement and Transplantation Network definition. Patients and methods. Our retrospective analysis studied 115 adult recipients of KT from January 2016 to July 2018, with kidney grafts procured from adult donors after brain or circulatory death, performed at our institute. Among the 2 recipients’ groups, we compared the incidence of …

AdultMalemedicine.medical_specialtyTissue and Organ ProcurementDelayed Graft FunctionSingle CenterMedicineHumansSurvival analysisKidney transplantationRetrospective StudiesTransplantationKidneyContinental Population Groupsbusiness.industryIncidence (epidemiology)IncidenceGraft SurvivalRacial GroupsRetrospective cohort studyMiddle Agedmedicine.diseaseKidney TransplantationSurvival AnalysisTissue DonorsSurgeryTransplantationsurgical procedures operativemedicine.anatomical_structureTreatment OutcomeSurgeryFemalebusinessBody mass indexTransplantation proceedings
researchProduct

ERAS Protocol for Perioperative Care of Patients Treated with Laparoscopic Nonanatomic Liver Resection for Hepatocellular Carcinoma: The ISMETT Exper…

2020

Background: Liver resection (LR) remains the best therapeutic option for patients with early-stage hepatocellular carcinoma (HCC) with preserved hepatic function and who are not eligible for liver transplantation. After its inception, the enhanced recovery after surgery (ERAS) protocol was widely used for treating patients with liver cancer, although there are still no clear indications for improving upon it in both open and laparoscopic surgery. Objective: This study aims to describe our institute's experience in the application of the ERAS protocol in a cohort of HCC patients, and to explore possible factors that could have an impact on postoperative outcomes. Materials and Methods: We re…

Laparoscopic surgeryLiver CirrhosisMalemedicine.medical_specialtyCirrhosisCarcinoma Hepatocellularmedicine.medical_treatmentLiver transplantation03 medical and health sciences0302 clinical medicinePostoperative ComplicationsmedicineHepatectomyHumansERASPostoperative PeriodAgedRetrospective StudiesAnalgesicsbusiness.industryNutritional SupportLiver NeoplasmsRetrospective cohort studyPerioperativehepatocellular carcinomalaparoscopic liver resectionLength of StayMiddle Agedmedicine.diseaseSurgery030220 oncology & carcinogenesisHepatocellular carcinomaoutcome030211 gastroenterology & hepatologySurgeryFemaleLaparoscopyHepatectomybusinessLiver cancerEnhanced Recovery After Surgery
researchProduct

Human Amnion-Derived Mesenchymal Stromal Cells: A New Potential Treatment for Carbapenem-Resistant Enterobacterales in Decompensated Cirrhosis

2022

Background: Spontaneous bacterial peritonitis (SBP) is a severe and often fatal infection in patients with decompensated cirrhosis and ascites. The only cure for SBP is antibiotic therapy, but the emerging problem of bacterial resistance requires novel therapeutic strategies. Human amniotic mesenchymal stromal cells (hA-MSCs) possess immunomodulatory and anti-inflammatory properties that can be harnessed as a therapy in such a context. Methods: An in vitro applications of hA-MSCs in ascitic fluid (AF) of cirrhotic patients, subsequently infected with carbapenem-resistant Enterobacterales, was performed. We evaluated the effects of hA-MSCs on bacterial load, innate immunity factors, and macr…

QH301-705.5Placentacirrhosis; ascitic fluid; spontaneous bacterial peritonitis; human amnion-derived mesenchymal stromal cells; carbapenem-resistant Enterobacterales; pattern recognition molecules; ficolins; complement; placentaComplementEnterobacterPeritonitisMesenchymal Stem Cell Transplantationbeta-Lactam ResistanceCatalysisImmunomodulationInorganic ChemistryPhagocytosisSpontaneous bacterial peritonitisHumansHuman amnion-derived mesenchymal stromal cellsAmnionBiology (General)Physical and Theoretical ChemistryQD1-999Complement ActivationMolecular BiologySpectroscopyAscitic fluidMacrophagesCarbapenem-resistant EnterobacteralesOrganic ChemistryPattern recognition moleculesEnterobacteriaceae InfectionsMesenchymal Stem CellsPeritoneal FibrosisFicolinsComplement System ProteinsGeneral MedicineBacterial LoadComputer Science ApplicationsChemistryTreatment OutcomeCirrhosisCarbapenemsReceptors Pattern RecognitionDisease SusceptibilityInflammation MediatorsBiomarkersInternational Journal of Molecular Sciences; Volume 23; Issue 2; Pages: 857
researchProduct

The addition of simvastatin administration to cold storage solution of explanted whole liver grafts for facing ischemia/reperfusion injury in an area…

2018

Abstract Background Liver transplantation is the best treatment for end-stage liver disease. The interruption of the blood supply to the donor liver during cold storage damages the liver, affecting how well the liver will function after transplant. The drug Simvastatin may help to protect donor livers against this damage and improve outcomes for transplant recipients. The aim of this study is to evaluate the benefits of treating the donor liver with Simvastatin compared with the standard transplant procedure. Patient and methods We propose a prospective, double-blinded, randomized phase 2 study of 2 parallel groups of eligible adult patients. We will compare 3-month, 6-month, and 12-month g…

medicine.medical_specialtySimvastatinmedicine.medical_treatmentlcsh:SurgeryCold storageIschemia/reperfusion injury030230 surgeryLiver transplantationDonor after brain deathPlaceboProtective Agents03 medical and health sciencesLiver diseaseStudy Protocol0302 clinical medicineDouble-Blind MethodDonor after brain death; Ischemia/reperfusion injury; Liver transplantation; SimvastatinMedicineHumansProspective StudiesLiver transplantationbusiness.industrylcsh:RD1-811General Medicinemedicine.diseaseSurgeryTransplantationFatty LiverRegimenLiverSimvastatinReperfusion Injury030211 gastroenterology & hepatologySurgerybusinessReperfusion injurymedicine.drugBMC surgery
researchProduct

Role of Allelic Imbalance in Predicting Hepatocellular Carcinoma (HCC) Recurrence Risk After Liver Transplant.

2019

BACKGROUND One of the most controversial problems for liver transplantation in patients affected by hepatocellular carcinoma (HCC) remains the lack of an oncologic staging system to predict cancer recurrence after liver transplantation (LT). We analyzed allelic imbalance (AI) in 19 microsatellites, and assessed the post-LT HCC recurrence risk. MATERIAL AND METHODS Seventy-one patients were included; 18 had tumor recurrence within 5 years post-transplant. Molecular analysis was done in the primary HCC and peripheral blood samples: a total of 19 microsatellites was used to assess AI. Specific AI was evaluated when outside of range value between 0.66 and 1.5. Based on data in the literature, w…

OncologyMalemedicine.medical_specialtyCarcinoma Hepatocellularmedicine.medical_treatmentLiver transplantationAllelic ImbalanceCancer recurrenceRecurrence risk03 medical and health sciences0302 clinical medicineRisk FactorsInternal medicinemedicineHumansIn patientAgedRetrospective StudiesTransplantationOriginal Paperbusiness.industryLiver NeoplasmsGeneral MedicineMiddle Agedmedicine.diseasePrognosisPeripheral bloodMolecular analysisLiver TransplantationTreatment Outcome030220 oncology & carcinogenesisHepatocellular carcinomaAllelic Imbalance030211 gastroenterology & hepatologyFemaleNeoplasm Recurrence LocalbusinessAllelic Imbalance Carcinoma Hepatocellular Liver Transplantation Treatment Outcome Aged Carcinoma Hepatocellular Female Humans Liver Neoplasms Male Middle Aged Neoplasm Recurrence Local Prognosis Retrospective Studies Risk Factors Treatment Outcome Allelic Imbalance Liver TransplantationAnnals of transplantation
researchProduct

Sicily Network for Liver Cancer: A Multidisciplinary Network Model for the Management of Primary Liver Tumors

2020

Background: The management of primary liver tumors requires the involvement of multiple specialist skills and the best possible treatment in terms of cost, risk, and benefit that could be provided by hepatobiliary or transplant surgeon, interventional radiologist, hepatologist, radiotherapist, or oncologist is needed to be chosen for each patient. This is particularly relevant for hepatocellular carcinoma (HCC), that is the most common primary liver tumor, and it occurs in more than 90% of cases in the setting of cirrhosis. Methods: To address the increasing complexity of cancer care, multidisciplinary tumor boards (MDTBs) have evolved to offer patients appropriate and tailored cancer treat…

Liver Cirrhosismedicine.medical_specialtyCirrhosisLiver tumorCarcinoma HepatocellularLiver Cirrhosicancer treatmentliver cancerMultidisciplinary approachHealth caremedicineHumansIntensive care medicineSicilyPatient Care Teambusiness.industryLiver Neoplasmshealth care modelCancerhepatocellular carcinomamedicine.diseaseSurgeryhealth care modelsLiver NeoplasmSicily.Hepatocellular carcinomanetworkSurgeryTransplant surgeonLiver cancerbusinesscholangiocarcinomaDelivery of Health CaremultidisciplinaryHuman
researchProduct

The use of normothermic machine perfusion to rescue liver allografts from expanded criteria donors

2021

The use of expanded criteria donors is one of the strategies used to overcome the gap between the demand for organs and the number of donors. Physicians debate the extent to which marginal grafts can be used. In recent years, normothermic machine perfusion (NMP) has been used to test liver viability before transplantation. Grafts underwent NMP whenever histological steatosis was > 40% or there were at least three Eurotransplant criteria for expanded criteria donor (ECD). We used NMP to test 19 grafts, 3 from donation after type 3 controlled cardiac death (DCD), and 16 from donation after brain death (DBD). Only two grafts from DBD were not transplanted, because perfusion proved they were…

medicine.medical_specialtyNormothermic machine perfusionmedicine.medical_treatmentLiver transplantationExpanded Criteria DonormedicineOverall survivalHumansMachine perfusionLiver transplantationbusiness.industryGraft SurvivalOrgan Preservationmedicine.diseaseAllograftsTissue DonorsDonation after brain deathSurgeryTransplantationPerfusionGraft viabilitysurgical procedures operativeLiverExpanded criteria donors Graft viability Hypothermic machine perfusion Liver transplantation Normothermic machine perfusionSurgerySteatosisExpanded criteria donorsbusinessPerfusionHypothermic machine perfusion
researchProduct

Mini-Invasive Approach Contributes to Expand the Indication for Liver Resection for Hepatocellular Carcinoma Without Increasing the Incidence of Post…

2016

Liver resection (LR) for hepatocellular carcinoma (HCC) is the best alternative option for increasing the survival of many patients with intermediate or advanced stages of the Barcelona Clinic Liver Cancer staging classification. Mini-invasive approach may play a positive role in treating a tumor rising almost exclusively in a diseased liver.A prospectively collected database was retrospectively reviewed for 167 consecutive patients who underwent LR between 1999 and 2015.A total of 38 LRs were performed from 1999 to 2009 (Period I), and 129 between 2010 and 2015 (Period II). Laparoscopic procedures increased from 5.3% to 38.1%. Not undergoing laparoscopic LR increased length of stay, and Cl…

AdultMalemedicine.medical_specialtyCarcinoma HepatocellularSingle Center03 medical and health sciences0302 clinical medicinePostoperative ComplicationsCarcinomaMedicineHepatectomyHumansLaparoscopyAgedRetrospective Studiesmedicine.diagnostic_testbusiness.industryIncidence (epidemiology)IncidenceLiver NeoplasmsRetrospective cohort studyPerioperativeMiddle Agedmedicine.diseaseSurgeryTreatment Outcome030220 oncology & carcinogenesisHepatocellular carcinoma030211 gastroenterology & hepatologySurgeryFemaleLaparoscopybusinessLiver cancerLiver Failure
researchProduct

How important is the role of iterative liver direct surgery in patients with hepatocellular carcinoma for a transplant center located in an area with…

2022

IntroductionHepatocellular carcinoma (HCC) accounts for nearly 90% of primary liver cancers, with estimates of over 1 million people affected by 2025. We aimed to explore the impacting role of an iterative surgical treatment approach in a cohort of HCC patients within the Milan criteria, associated with clinical risk factors for tumor recurrence (RHCC) after liver transplant (LT) and loco-regional therapies (LRT), as well as liver resection (LR) and/or microwave thermal ablation (MWTA).MethodsWe retrospectively analyzed our experience performed during an 8-year period between January 2013 and December 2021 in patients treated for HCC, focusing on describing the impact on preoperative end-st…

thermal ablationCancer Researchliver transplantationOncologyliver resectionhepatocellular carcinomalaparoscopicFrontiers in Oncology
researchProduct

Single center report on complications in steroid-free immunosuppressive therapy of liver transplant recipients

2010

Steroid-Free Immunosuppressive Therapy Liver Transplant Recipients
researchProduct

Peri-Operative Liver Regeneration of the Remnant Liver Volume after Right Hepatectomy for Living Donation: A Multiple Regression Analysis

2012

Early liver regeneration was studied in a series of 70 patients who underwent right hepatectomy for living donation from November 2004 to January 2010. Liver regeneration was evaluated by multidetector computed tomography at a mean time of 61.07 days after surgery. Pre-surgical variables such as age, weight, height, body mass index, liver function tests, creatinine, platelet count, international normalized ratio, glucose, and variables detected with preoperative multidetector computed tomography imaging, including diameter of main portal vein, steatosis, original liver volume and spleen volume, were investigated as potential predictors of liver regeneration. Future remnant liver volume was …

Early liver regeneration remnant liver volume after right hepatectomy for living donation
researchProduct

Benign liver lesions 2022: Guideline for clinical practice of Associazione Italiana Studio del Fegato (AISF), Società Italiana di Radiologia Medica e…

2022

Benign liver lesions are increasingly diagnosed in daily clinical practice due to the growing use of imaging techniques for the study of the abdomen in patients who have non-specific symptoms and do not have an increased risk of hepatic malignancy. They include simple or parasitic cysts and solid benign tumors which differ widely in terms of prevalence, clinical relevance, symptoms and natural history and often lead to significant clinical problems relating to diagnosis and clinical management. Following the need to have updated guidelines on the management of benign focal liver lesions, the Scientific Societies mainly involved in their management have promoted the drafting of a new dedicat…

Settore MED/09 - Medicina InternaComplicated hepatic cystHepatologyComplicated hepatic cyst Focal liver lesion Parasitic hepatic cyst Polycystic liver disease Simple hepatic cyst HumansAbdomen Italy Digestive System Diseases Cysts Liver NeoplasmsDigestive System DiseasesSettore MED/18 - CHIRURGIA GENERALELiver NeoplasmsFocal liver lesion Focal nodular hyperplasia Hepatic hemangioma Hepatocellular adenomaGastroenterologyHepatic hemangiomaSimple hepatic cystHepatocellular adenomaPolycystic liver diseaseItalyAbdomenFocal liver lesionFocal nodular hyperplasiaHumansParasitic hepatic cystDigestive and Liver Disease
researchProduct

LAPAROSCOPIC LEFT LIVER SECTIONECTOMY (LLLS) FOR PEDIATRIC LIVING RELATED LIVER TRANSPLANTATION (LRLT)

2011

PURPOSE: LRLT in children is a method to provide organs for transplantation. We report 2 cases of LLLS for pediatric LRLT. METHOD: Donor position: lithotomy with surgeon in French position. Trocars: three 12 mm, placed 2 cm upper the supra-umbilical mid-line and sub-costal bi-lateral on the nipple lines; one 5 mm in epigastrium. Special instrumentation: harmonic scissor, ligasure®, Hem-O-Lock clips, and Endo Catch-II® bag. Main steps: division of round, falciform, left triangular ligaments and of lesser omentum; inspection of anatomy; hepatic hilum dissection with exposure of the left hepatic artery; dissection of the right side of the falciform ligament with exposure of the left branch of …

Settore MED/18 - Chirurgia Generaleliving donation laparoscopic hepatectomy pediatric transplantation
researchProduct

Additional file 1 of Case report: Trans-papillary free stenting of the cystic duct and of the common bile duct in a double biliary ducts anastomoses …

2021

Additional file 1: Video. Imaging evaluation and surgical maneuvers.

ComputingMethodologies_SIMULATIONANDMODELINGData_FILESComputingMethodologies_IMAGEPROCESSINGANDCOMPUTERVISIONComputerApplications_COMPUTERSINOTHERSYSTEMSComputingMethodologies_COMPUTERGRAPHICS
researchProduct